|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.5800 - 0.5800|
|52 Week Range||0.1000 - 0.7500|
|Beta (5Y Monthly)||3.40|
|PE Ratio (TTM)||30.53|
|Earnings Date||Nov 13, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Fuse Medical, Inc., (FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the results of its 2019 Annual Shareholder Meeting that was held on Wednesday, June 26, 2019. Election of Directors: All five directors named in the proxy statement were re-elected to serve on the Company’s Board of Directors: Mark W. Brooks, Christopher C. Reeg, William E. McLaughlin, III, Renato V. Bosita Jr., MD and Ricky Raj S. Kalra, MD. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased the shareholders of Fuse have shown their confidence with the Executive team by electing them to serve as Directors for another year.
Fuse Medical, Inc., (FZMD), a distributor and an emerging manufacturer of medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our first quarter of 2019 results, with an eleven (11) percentage point increase to gross profit and one (1) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. The filing can be found on the Company’s website at http://www.fusemedical.com/investors.
Fuse Medical, Inc., , an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.
Fuse Medical, Inc., , , announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share , is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.